MiMedx Group Inc (MDXG)
7.65
+0.04
(+0.53%)
USD |
NASDAQ |
Mar 28, 11:26
MiMedx Group Cash from Operations (TTM): 26.78M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 26.78M |
September 30, 2023 | 10.89M |
June 30, 2023 | -0.938M |
March 31, 2023 | -11.72M |
December 31, 2022 | -17.89M |
September 30, 2022 | -15.50M |
June 30, 2022 | -10.13M |
March 31, 2022 | -5.526M |
December 31, 2021 | -1.982M |
September 30, 2021 | -9.017M |
June 30, 2021 | -19.96M |
March 31, 2021 | -24.66M |
December 31, 2020 | -30.26M |
September 30, 2020 | -43.12M |
June 30, 2020 | -41.66M |
March 31, 2020 | -36.43M |
December 31, 2019 | -39.41M |
September 30, 2019 | -14.76M |
June 30, 2019 | -8.199M |
March 31, 2019 | 10.36M |
December 31, 2018 | 35.80M |
September 30, 2018 | 55.13M |
June 30, 2018 | 69.68M |
March 31, 2018 | 62.48M |
December 31, 2017 | 62.94M |
Date | Value |
---|---|
September 30, 2017 | 56.78M |
June 30, 2017 | 41.67M |
March 31, 2017 | 35.47M |
December 31, 2016 | 23.85M |
September 30, 2016 | 13.50M |
June 30, 2016 | 17.97M |
March 31, 2016 | 13.62M |
December 31, 2015 | 18.81M |
September 30, 2015 | 22.74M |
June 30, 2015 | 24.38M |
March 31, 2015 | 22.62M |
December 31, 2014 | 16.80M |
September 30, 2014 | 9.357M |
June 30, 2014 | 2.138M |
March 31, 2014 | 0.2022M |
December 31, 2013 | -0.284M |
September 30, 2013 | -1.996M |
June 30, 2013 | -4.587M |
March 31, 2013 | -4.142M |
December 31, 2012 | -3.332M |
September 30, 2012 | -4.117M |
June 30, 2012 | -4.344M |
March 31, 2012 | -6.163M |
December 31, 2011 | -6.665M |
September 30, 2011 | -6.995M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-43.12M
Minimum
Sep 2020
26.78M
Maximum
Dec 2023
-14.16M
Average
-13.24M
Median
Cash from Operations (TTM) Benchmarks
TELA Bio Inc | -40.86M |
Amylyx Pharmaceuticals Inc | 11.92M |
CEL-SCI Corp | -23.07M |
AIM ImmunoTech Inc | -17.58M |
IGC Pharma Inc | -6.19M |